Andrew Solomon, PhD
LecturerCards
About
Research
Publications
2026
Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study
Scharf A, Cohen J, Marrie R, Miller A, Waubant E, Kilbane M, Luskin E, Azevedo C, Dever M, Alvarez E, Calabresi P, Chahin S, Freeman L, Nakamura K, Longbrake E, Mowry E, Oh J, Rodrigues P, Ramos M, Sotirchos E, Cutter G, Kaisey M, Amin M, Toljan K, Illenberger N, Bilello M, Lee J, Maya M, Obusez E, Schindler M, Suthiphosuwan S, Ulano A, Shinohara R, Reich D, Solomon A, Sicotte N, Sati P, Ontaneda D. Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study. Neurology 2026, 107: e218183. PMID: 42284534, PMCID: PMC13267864, DOI: 10.1212/wnl.0000000000218183.Peer-Reviewed Original ResearchDiagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosis
Toljan K, Renner B, Daboul L, Martin M, Cao Q, O'Donnell C, Rodrigues P, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi P, Cree B, Freeman L, Henry R, Longbrake E, Nakamura K, Oh J, Papinutto N, Pelletier D, Samudralwar R, Schindler M, Sotirchos E, Sicotte N, Solomon A, Shinohara R, Reich D, Sati P, Ontaneda D. Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosis. Multiple Sclerosis Journal 2026, 32: 614-623. PMID: 42010983, PMCID: PMC13138446, DOI: 10.1177/13524585261434218.Peer-Reviewed Original ResearchSuperior visibility of paramagnetic rim lesions on filtered phase versus SWI.
Lee J, Renner B, Madhusoodhanan Nair S, Nakamura K, Luskin E, Shinohara R, Reich D, Solomon A, Sicotte N, Ontaneda D, Sati P. Superior visibility of paramagnetic rim lesions on filtered phase versus SWI. American Journal Of Neuroradiology 2026, ajnr.a9295. PMID: 41826064, DOI: 10.3174/ajnr.a9295.Peer-Reviewed Original ResearchAccess and barriers to diagnosis of multiple sclerosis in Iran - A clinician survey
Khodadadi S, Bahrami S, Jahani S, Sahraian M, Solomon A. Access and barriers to diagnosis of multiple sclerosis in Iran - A clinician survey. Multiple Sclerosis And Related Disorders 2026, 109: 107089. PMID: 41832843, DOI: 10.1016/j.msard.2026.107089.Peer-Reviewed Original ResearchAre neurofilament light chain levels ready for routine clinical use? – No
Sotirchos E, Solomon A. Are neurofilament light chain levels ready for routine clinical use? – No. Multiple Sclerosis Journal 2026, 32: 673-675. PMID: 41711385, DOI: 10.1177/13524585261423029.Peer-Reviewed Original ResearchComparison of central FLAIR hypointensity and central vein sign on FLAIR* in a diagnostic cohort
Toljan K, Amin M, Daboul L, Nakamura K, Solomon A, Sicotte N, Shinohara R, Reich D, Sati P, Ontaneda D. Comparison of central FLAIR hypointensity and central vein sign on FLAIR* in a diagnostic cohort. European Journal Of Radiology 2026, 196: 112707. PMID: 41628503, DOI: 10.1016/j.ejrad.2026.112707.Peer-Reviewed Original Research
2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis
Spain R, Paz Soldán M, Freedman M, Repovic P, Solomon A, Rinker J, Wallin M, Haselkorn J, Stuve O, Gross R, Waslo C, Hildebrand A, Morris C, Mitchell J, Turner A, Schwartz D, Metz J, Rooney W. Lipoic Acid for Treatment of Progressive Multiple Sclerosis. Neurology 2025, 106: e214454. PMID: 41397213, PMCID: PMC12714125, DOI: 10.1212/wnl.0000000000214454.Peer-Reviewed Original ResearchThe revised 2024 McDonald criteria can solve the misdiagnosis problem in multiple sclerosis: Yes
Ramanathan S, Solomon A. The revised 2024 McDonald criteria can solve the misdiagnosis problem in multiple sclerosis: Yes. Multiple Sclerosis Journal 2025, 32: 163-164. PMID: 41388897, DOI: 10.1177/13524585251396284.Peer-Reviewed Original ResearchDiagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Montalban X, Lebrun-Frénay C, Oh J, Arrambide G, Moccia M, Pia Amato M, Amezcua L, Banwell B, Bar-Or A, Barkhof F, Butzkueven H, Ciccarelli O, Chataway J, Cohen J, Comi G, Correale J, Deisenhammer F, Filippi M, Fiol J, Freedman M, Fujihara K, Granziera C, Green A, Hartung H, Hellwig K, Kappos L, Kimbrough D, Killestein J, Lublin F, Marignier R, Marrie R, Miller A, Otero-Romero S, Ontaneda D, Ramanathan S, Reich D, Rocca M, Rovira À, Saidha S, Salter A, Sastre-Garriga J, Saylor D, Solomon A, Sormani M, Stankoff B, Tintore M, Tremlett H, Van der Walt A, Viswanathan S, Wiendl H, Wildemann B, Yamout B, Zaratin P, Calabresi P, Coetzee T, Thompson A. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. The Lancet Neurology 2025, 24: 850-865. PMID: 40975101, DOI: 10.1016/s1474-4422(25)00270-4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThe 2024 revisions of the McDonald criteria pose risk of multiple sclerosis overdiagnosis
Solomon A, Brodersen J. The 2024 revisions of the McDonald criteria pose risk of multiple sclerosis overdiagnosis. Nature Reviews Neurology 2025, 21: 659-660. PMID: 40962996, DOI: 10.1038/s41582-025-01140-4.Peer-Reviewed Original Research
News
Get In Touch
Contacts
Mailing Address
Yale University
18 West 10th Street
New York, NY 10011-8702
United States